General
Preferred name
PARECOXIB
Synonyms
SC 69124 ()
Vorth-P ()
Valus-P ()
PARECOXIB SODIUM ()
Parecoxib (Sodium) ()
SC 69124A ()
SC-69124, Valus-P, Vorth-P ()
SC-69124 Sodium ()
Rayzon ()
Xapit ()
SC-69124 ()
Dynastat ()
SC-69124A ()
Parecoxib sodium salt ()
Parecoxib (sodium salt) ()
P&D ID
PD009212
CAS
197502-82-2
198470-85-8
198470-84-7
Tags
available
drug
prodrug
Approved by
EMA
First approval
2002
Drug Status
approved
investigational
withdrawn
Max Phase
4.0
Drug indication
Osteoarthritis
rheumatic disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Parecoxib Sodium (SC 69124A) is a highly selective and orally active COX-2 inhibitor, the proagent of Valdecoxib (HY-15762). Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. Parecoxib Sodium can be used for the relief of acute postoperative pain and symptoms of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis in vivo.
DESCRIPTION
The brand Dynastat® contains parecoxib sodium (PubChem CID 15895902). Parecoxib is a water soluble prodrug of valdecoxib, a non‑steroidal anti‑inflammatory drug (NSAID).
(GtoPdb)
PRICE
29
DESCRIPTION
Parecoxib (SC 69124) is a highly selective and orally active COX-2 inhibitor, the proagent of Valdecoxib (HY-15762). Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. Parecoxib can be used for the relief of acute postoperative pain and symptoms of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis in vivo.
DESCRIPTION
Parecoxib is a selective COX-2 inhibitor and NSAID used for the short-term management of perioperative pain.
(Enamine Bioactive Compounds)
DESCRIPTION
Parecoxib (SC 69124) is an effective and selective COX-2 inhibitor.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
22
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMatrix
Enamine Bioactive Compounds
Guide to Pharmacology
Ki Database
NIH Clinical Collections (NCC)
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
107
Molecular Weight
370.1
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
3
cLogP
3.53
TPSA
89.27
Fraction CSP3
0.16
Chiral centers
0.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
COX
COX-2
LTF
Selective COX-2 inhibitor
Indication
pain relief
MOA
cyclooxygenase inhibitor
ATC
M01AH04
Pathway
Immunology/Inflammation
Neuroscience
Source data

